DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to ...

Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

The human touch matters when developing treatments. The Fast Company Impact Council is an invitation-only membership ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

The feature highlights his groundbreaking contributions to the use of artificial intelligence in computational drug modeling and the development of the Deep Docking™ platform—an AI engine capable of ...